ECSP941088A - Composiciones - Google Patents
ComposicionesInfo
- Publication number
- ECSP941088A ECSP941088A EC1994001088A ECSP941088A ECSP941088A EC SP941088 A ECSP941088 A EC SP941088A EC 1994001088 A EC1994001088 A EC 1994001088A EC SP941088 A ECSP941088 A EC SP941088A EC SP941088 A ECSP941088 A EC SP941088A
- Authority
- EC
- Ecuador
- Prior art keywords
- methyl
- pharmaceutically acceptable
- compositions
- hydroxytryptamine
- imidazol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 102000035037 5-HT3 receptors Human genes 0.000 abstract 1
- 108091005477 5-HT3 receptors Proteins 0.000 abstract 1
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se relaciona con una composición farmacéutica para administración rectal que comprende 1, 2, 3, 9- tetrahidro-9-metil-3-((2-metil-1H-imidazol-1-il)-metil)-4H-carbazol-4-ona, en forma de su base libre, o de un solvato farmacéuticamente aceptable de la misma, como ingrediente activo, junto con uno o más portadores o excipientes farmacéuticamente aceptables. También se describen métodos para la manufactura de estas composiciones y para su uso en el tratamiento de las condiciones mediadas a través de la acción de la 5-hidroxitriptamina en los receptores 5-HT3.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310756A GB9310756D0 (en) | 1993-05-25 | 1993-05-25 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP941088A true ECSP941088A (es) | 1994-11-16 |
Family
ID=10736089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC1994001088A ECSP941088A (es) | 1993-05-25 | 1994-05-17 | Composiciones |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US5741806A (es) |
| EP (1) | EP0700290B1 (es) |
| JP (1) | JP2965703B2 (es) |
| KR (1) | KR100297212B1 (es) |
| CN (1) | CN1106194C (es) |
| AP (1) | AP544A (es) |
| AT (1) | ATE183643T1 (es) |
| AU (1) | AU680918B2 (es) |
| BE (1) | BE1007158A3 (es) |
| BR (1) | BR1100046A (es) |
| CA (1) | CA2162919C (es) |
| CO (1) | CO4230094A1 (es) |
| CY (1) | CY2411B1 (es) |
| CZ (1) | CZ291041B6 (es) |
| DE (1) | DE69420266T2 (es) |
| DK (1) | DK0700290T3 (es) |
| EC (1) | ECSP941088A (es) |
| ES (1) | ES2136198T3 (es) |
| FR (1) | FR2705569B1 (es) |
| GB (2) | GB9310756D0 (es) |
| GR (1) | GR3031669T3 (es) |
| HR (2) | HRP940315B1 (es) |
| HU (1) | HU227121B1 (es) |
| IE (1) | IE80632B1 (es) |
| IL (1) | IL109749A (es) |
| IS (1) | IS1868B (es) |
| IT (1) | IT1272990B (es) |
| MY (1) | MY111445A (es) |
| NO (1) | NO306448B1 (es) |
| NZ (1) | NZ267415A (es) |
| PE (1) | PE13395A1 (es) |
| PL (1) | PL175578B1 (es) |
| RU (1) | RU2132684C1 (es) |
| SA (1) | SA94150003B1 (es) |
| SG (1) | SG48119A1 (es) |
| SI (1) | SI0700290T1 (es) |
| WO (1) | WO1994027599A1 (es) |
| ZA (1) | ZA943593B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060067986A (ko) * | 1998-06-15 | 2006-06-20 | 세프라코 아이엔시. | 무호흡증, 대식증, 다른 질환을 치료하기 위한 광학적으로순수한 (+)-노르씨사프라이드의 용도 |
| EP1464333A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| EP1468685A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| TR200003707T2 (tr) * | 1998-06-15 | 2001-06-21 | Sepracor Inc. | Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
| US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| JP5048201B2 (ja) * | 2000-08-04 | 2012-10-17 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| PH22672A (en) * | 1984-01-25 | 1988-11-14 | Glaxo Group Ltd | Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| GB8627909D0 (en) * | 1986-11-21 | 1986-12-31 | Glaxo Group Ltd | Medicaments |
| GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
| GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
| US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
-
1994
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active Expired - Lifetime
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en not_active Ceased
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
-
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
-
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
-
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
-
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
-
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR002355A1 (es) | Composiciones y metodos para administracion local de agentes farmaceuticamente activos. | |
| AR028833A1 (es) | Compuestos inhibidores de metaloproteasas, composiciones farmaceuticas, uso para la manufactura de medicamentos, metodo de tratamiento y procedimiento para su preparacion | |
| IT1282352B1 (it) | Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per | |
| ES2117015T3 (es) | Composiciones que contienen sumatriptan. | |
| SE9504661D0 (sv) | New compounds | |
| ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| AR029605A1 (es) | DERIVADOS DE DIFENILUREA SUBSTITUIDOS CON SULFONAMIDA , COMPOSICIoN FARMACEUTICA , USO DE LOS MISMOS PARA LA MANUFACTURA DE UN MEDICAMENTO uTILES COMO ANTAGONISTA DE RECEPTORES DE IL-8, COMPUESTOS, INTERMEDIARIOS, Y MÉTODOS DE CONVERSIoN DE COMPUESTOS | |
| AR026593A1 (es) | Formulaciones para agentes farmaceuticos ionizables como acidos libres o bases libres | |
| SE9900961D0 (sv) | Novel compounds | |
| ES2188426B1 (es) | Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias. | |
| ECSP055528A (es) | Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco | |
| AR029941A1 (es) | Compuestos utiles para elevar el nivel plasmatico de la hormona del crecimiento y las composiciones farmaceuticas que las contienen | |
| CO5160321A1 (es) | Novedosas composiciones de tipranavir y ritonavir | |
| AR024998A1 (es) | Nuevos retinoides para el tratamiento del enfisema | |
| SE0102055D0 (sv) | New Compounds | |
| AR128066A1 (es) | Compuesto heterocíclico de pirimidina y método de preparación y uso médico de los mismos | |
| ES2113533T3 (es) | Composiciones farmaceuticas de alquilsulfonamidas agonistas de 5-ht1 para administracion rectal. | |
| DK0527081T3 (da) | Hidtil ukendte substituerede 3-piperazinylalkyl-2,3-dihydro-1,3-4H-benzoxazin-4-oner, deres fremstilling og terapeutiske anvendelse | |
| ES2136198T3 (es) | Composiciones rectales que contienen odansetron en forma de su base libre. | |
| AR011697A1 (es) | Composiciones farmaceuticas, uso de lamivudina en la manufactura de tales composiciones farmaceuticas. | |
| ES2145234T3 (es) | Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| SE9504662D0 (sv) | New compounds | |
| ATE44461T1 (de) | Analgetische zusammensetzungen. | |
| EA200300430A1 (ru) | Новые фармацевтические композиции, содержащие эпинастин и псевдоэфедрин | |
| AR010344A1 (es) | Uso de equilenina o una sal farmaceuticamente aceptable del ester de equilenina-3-sulfato para la manufactura de un medicamento util para inhibir otratar patologias inducidas por los radicales libres y composiciones farmaceuticas |